Authors: KLEIM JP BENDER R KIRSCH R MEICHSNER C PAESSENS A ROSNER M RUBSAMENWAIGMANN H KAISER R WICHERS M SCHNEWEIS KE WINKLER I RIESS G

Citation: Jp. Kleim et al., PRECLINICAL EVALUATION OF HBY-097, A NEW NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION, Antimicrobial agents and chemotherapy, 39(10), 1995, pp. 2253-2257

Authors: PEYMAN A WAGNER K BUDT KH SPANIG J RUPPERT D MEICHSNER C PAESSENS A

Citation: A. Peyman et al., INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE BY A C(2)-SYMMETRICAL PHOSPHINIC ACID AMIDE, Bioorganic & medicinal chemistry letters, 4(10), 1994, pp. 1191-1194

Authors: KLEIM JP BENDER R KIRSCH R MEICHSNER C PAESSENS A RIESS G

Citation: Jp. Kleim et al., MUTATIONAL ANALYSIS OF RESIDUE-190 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE, Virology, 200(2), 1994, pp. 696-701

Authors: BALZARINI J KARLSSON A MEICHSNER C PAESSENS A RIESS G DECLERCQ E KLEIM JP

Citation: J. Balzarini et al., RESISTANCE PATTERN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE TO QUINOXALINE S-2720, Journal of virology, 68(12), 1994, pp. 7986-7992

Authors: KLEIM JP BENDER R BILHARDT UM MEICHSNER C PAESSENS A REISS G ROSNER M WINKLER I

Citation: Jp. Kleim et al., A QUINOXALINE DERIVATIVE WITH HIGH INHIBITORY ACTIVITY AGAINST HIV-1 DEFINES A NEW BINDING-SITE ON THE REVERSE-TRANSCRIPTASE, Journal of cellular biochemistry, 1993, pp. 16-16

Authors: KLEIM JP BENDER R BILLHARDT UM MEICHSNER C RIESS G ROSNER M WINKLER I PAESSENS A

Citation: Jp. Kleim et al., ACTIVITY OF A NOVEL QUINOXALINE DERIVATIVE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE AND VIRAL REPLICATION, Antimicrobial agents and chemotherapy, 37(8), 1993, pp. 1659-1664